Boulder, CO, United States of America

Chan Kou Hwang


Average Co-Inventor Count = 4.9

ph-index = 5

Forward Citations = 94(Granted Patents)


Location History:

  • San Diego, CA (US) (1996 - 1998)
  • Boulder, CO (US) (1998 - 2003)

Company Filing History:


Years Active: 1996-2003

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Mind of Chan Kou Hwang: Patenting New Frontiers in Pharmaceuticals

Introduction: Chan Kou Hwang, an accomplished inventor based in Boulder, CO, has made significant strides in the field of pharmaceuticals with a total of seven patents to her name. Her work focuses on innovative methods and compounds that enhance therapeutic applications, particularly within the realm of nuclear receptors.

Latest Patents: Among her most recent patents, Hwang has developed dimer-selective RXR modulators and methods for their use. These modulators exhibit agonist, partial agonist, and antagonist activity when utilized in the context of RXR homodimers and RXR heterodimers. Moreover, her patent also encompasses pharmaceutical compositions that incorporate these dimer-selective RXR modulator compounds, thereby offering potential methods for therapeutic use. Another key invention by Hwang includes methods for the stereospecific synthesis of 11,13-cis polyene esters. This innovative technique allows for the creation of 9-cis olefins and retinoids through the lactol ring opening, maintaining complete retention of double bond configuration.

Career Highlights: Chan Kou Hwang has cultivated an impressive career at Ligand Pharmaceuticals, Inc., a leading pharmaceutical company. Her contributions have been instrumental in advancing the understanding and applications of RXR modulators, providing new avenues for drug development and treatment strategies.

Collaborations: Throughout her career, Hwang has worked closely with esteemed colleagues such as Alex M Nadzan and Steven K White. Their collaborative efforts in research and development have played a crucial role in bringing transformative innovations to the pharmaceutical industry.

Conclusion: Chan Kou Hwang's pioneering work and her seven patents reflect her dedication to advancing the field of pharmaceuticals. Her innovative contributions, particularly involving RXR modulators and stereospecific synthesis methods, not only showcase her expertise but also enhance therapeutic potentials in medicine. As Hwang continues her work at Ligand Pharmaceuticals, the impact of her inventions is sure to resonate throughout the industry and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…